Candriam Luxembourg S.C.A. increased its stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 45.1% during the second quarter, Holdings Channel reports. The firm owned 14,866 shares of the medical equipment provider’s stock after buying an additional 4,621 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Varian Medical Systems were worth $1,534,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. First Mercantile Trust Co. boosted its position in shares of Varian Medical Systems by 2.3% in the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock valued at $100,000 after buying an additional 25 shares during the period. Parallel Advisors LLC boosted its position in shares of Varian Medical Systems by 16.7% in the first quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock valued at $113,000 after buying an additional 176 shares during the period. Heritage Trust Co bought a new position in shares of Varian Medical Systems during the first quarter valued at about $118,000. Penserra Capital Management LLC boosted its position in shares of Varian Medical Systems by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,610 shares of the medical equipment provider’s stock valued at $146,000 after buying an additional 140 shares during the period. Finally, Pacer Advisors Inc. boosted its position in shares of Varian Medical Systems by 3.1% in the first quarter. Pacer Advisors Inc. now owns 1,815 shares of the medical equipment provider’s stock valued at $165,000 after buying an additional 55 shares during the period. Hedge funds and other institutional investors own 99.27% of the company’s stock.

Varian Medical Systems, Inc. (NYSE VAR) opened at 97.74 on Friday. The firm has a market cap of $8.97 billion, a PE ratio of 32.17 and a beta of 0.61. The firm’s 50-day moving average price is $101.70 and its 200 day moving average price is $93.39. Varian Medical Systems, Inc. has a 52-week low of $75.20 and a 52-week high of $107.08.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 EPS for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.09. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. The business had revenue of $662.40 million for the quarter, compared to analyst estimates of $663.86 million. During the same quarter last year, the business earned $1.00 earnings per share. The business’s revenue for the quarter was up 3.0% on a year-over-year basis. On average, equities analysts anticipate that Varian Medical Systems, Inc. will post $3.94 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Candriam Luxembourg S.C.A. Buys 4,621 Shares of Varian Medical Systems, Inc. (VAR)” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/candriam-luxembourg-s-c-a-buys-4621-shares-of-varian-medical-systems-inc-var/1476996.html.

VAR has been the topic of several recent research reports. TheStreet upgraded Varian Medical Systems from a “c+” rating to a “b+” rating in a research report on Wednesday, April 26th. Citigroup Inc. upgraded Varian Medical Systems from a “neutral” rating to a “buy” rating in a research report on Monday, May 15th. Jefferies Group LLC restated a “buy” rating on shares of Varian Medical Systems in a research report on Thursday, May 11th. BTIG Research upgraded Varian Medical Systems from a “neutral” rating to a “buy” rating and set a $106.00 price target on the stock in a research report on Monday, May 8th. Finally, BidaskClub cut Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $96.28.

In related news, insider Dow R. Wilson sold 15,059 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $96.48, for a total transaction of $1,452,892.32. Following the transaction, the insider now owns 81,835 shares in the company, valued at $7,895,440.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP John W. Kuo sold 19,819 shares of the firm’s stock in a transaction that occurred on Wednesday, May 31st. The shares were sold at an average price of $99.67, for a total transaction of $1,975,359.73. Following the transaction, the senior vice president now owns 47,180 shares in the company, valued at approximately $4,702,430.60. The disclosure for this sale can be found here. Insiders have sold 158,284 shares of company stock worth $16,022,132 in the last quarter. Company insiders own 0.91% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.